| + |
STAT1 | up-regulates quantity by expression
transcriptional regulation
|
TAP1 |
0.274 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254531 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 15778351 |
We also show that this cytokine-dependent expression of TAP1 transcripts depends on STAT1 and IFN regulatory factor-2 (IRF-2), but not on IRF-1, and provide evidence that IRF-2 constitutively binds to the TAP1 gene promoter and enhances TAP1 promoter activity. We show that IRF-2 forms a complex with STAT1 and the cytokine-responsive region of the TAP1 promoter in any TPO or IFN-gamma target cells tested. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
TAP1 | down-regulates quantity
relocalization
|
oligopeptide |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-267778 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 31810556 |
Following cytosolic proteolysis, antigenic peptides are recruited to the ER and translocated to its lumen by the Transporter associated with Antigen Processing (TAP). |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
regorafenib | down-regulates activity
chemical inhibition
|
TAP1 |
0.8 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-259204 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 26254357 |
It is suggested that in vitro, regorafenib is an inhibitor of ABCB1 and ABCG2, but not a substrate, and that its active metabolites, M2 (N-Oxide metabolite) and M5 (N-Oxide/N-desmethyl metabolite), are substrates of ABCB1 and ABCG3 |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |
| + |
IRF2 | up-regulates quantity by expression
transcriptional regulation
|
TAP1 |
0.2 |
| Identifier |
Residue |
Sequence |
Organism |
Cell Line |
| SIGNOR-254530 |
|
|
Homo sapiens |
|
| pmid |
sentence |
| 15778351 |
We also show that this cytokine-dependent expression of TAP1 transcripts depends on STAT1 and IFN regulatory factor-2 (IRF-2), but not on IRF-1, and provide evidence that IRF-2 constitutively binds to the TAP1 gene promoter and enhances TAP1 promoter activity. |
|
| Publications: |
1 |
Organism: |
Homo Sapiens |